Management of Intractable, Cirrhotic Ascites with an Indwelling Drainage Catheter

Journal of Palliative Medicine

Volumn 6, Issue 5, 2003, Pages 787-791

  Reisfield, Gary M ^a   Wilson, George R ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; FUROSEMIDE; LACTULOSE; PANTOPRAZOLE; PAROXETINE; RAMIPRIL; SALBUTAMOL; SPIRONOLACTONE; THIAMINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ASCITES; BLOOD CLOTTING DISORDER; CASE REPORT; ESOPHAGUS VARICES; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPICE CARE; HUMAN; INDWELLING CATHETER; MALE; PALLIATIVE THERAPY; PARACENTESIS; PERITONEAL CATHETER; PERITONEUM VEIN SHUNT; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; ARTICLE; INSTRUMENTATION; WOUND DRAINAGE;

ADULT; ASCITES; DRAINAGE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; PALLIATIVE CARE;

EID: 1542540024     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662103322515365     Document Type: Review

References (24)

1. Garcia N, Sanyal AJ: Ascites. Curr Treat Options Gastroenterol 2001;4:527-537.
2. Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, Torres M, Humbert P, Rimola A, Llach J, et al: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-1502.
3. Kao HW, Rakov NE, Savage E, Reynolds TB: The effect of large volume paracentesis on plasma volume-A cause of hypovolemia? Hepatology 1985;5:403-407.
4. Antillon MR, Runyon BA: Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality? Gastroenterology 1991;101:1456-1457.
5. Garcia N, Sanyal AJ. Minimizing ascites. Postgrad Med 2001;109:91-99.
6. Forouzandeh B, Konicek F, Sheagren JN: Large volume paracentesis in the treatment of cirrhotic patients with refractory ascites. J Clin Gastroenterol 1996;22: 207-210.
7. Suzuki H, Stanley AJ: Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. Q J Med 2001;94:293-300.
8. Orsi F, Grasso RF, Bonomo G, Monti C, Marinucci I, Bellomi M: Percutaneous peritoneovenous shunt positioning: Technique and preliminary results. Eur Radiol 2002;12:1188-1192.
9. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T: The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003;124:634-641.
10. Bellis L, Moitinho E, Abraldes JG, Graupera M, Garcia-Pagan JC, Rodes J, Bosch J: Acute propranolol administration effectively decreases portal pressure in patients with TIPS dysfunction. Gut 2003;52:130-133.
11. Chutaputti A: Advances in liver disease: alcoholic hepatitis, non-cirrhotic portal fibrosis and complications of cirrhosis. J Gastroent Hepatol 2002;17:456-461.
12. Zervos EE, McCormick J, Goode SE, Rosemurgy AS: Peritoneovenous shunts in patients with intractable ascites: Palliation at what price? Am Surg 1997;63: 157-162.
13. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS: Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989;321: 1632-1638.
14. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladoniu L, Rimila A, Morillas R: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991;325: 829-835.
15. Suzuki H, Stanley AJ: Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome. Q J Med 2001;94:293-300.
16. Runyon BA: Management of adult patients with ascites caused by cirrhosis. Hepatology 1997;27:264-272.
17. Pollak JS: Malignant pleural effusions: treatment with tunneled long-term drainage catheters. Curr Opin Pulm Med 2002;8:302-307.
18. Iyengar TD, Herzog TJ: Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hosp Palliat Care 2002;19:35-38.
19. Richard HM, Coldwell DM, Boyd-Kranis RL, Murthy R, Van Echo DA: Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 2001;12:373-375.
20. Friedman LS: The risk of surgery in patients with liver disease. Hepatology 1999;74:1617-1623.
21. Amitrano L, Guardascione MA, Brancaccio V, Balzano A: Coagulation disorders in liver disease. Semin Liver Dis 2002;22:83-96.
22. Garcia N, Sanyal A: Minimizing ascites. Postgrad Med 2001;109:91-99.
23. Romero A, Perez-Arellano JL, Gonzalez-Villaron L, Brock JH, Munoz-Bellido JL, de Castro S: Effect of transferrin concentration on bacterial growth in human ascitic fluid from cirrhotic and neoplastic patients. Eur J Clin Invest 1993;23:699-705.
24. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM: Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA 1989;261:878-883.